Tag: pharmaceuticals
Ault Global Holdings Announces Adtech Pharma, Inc., an Innovative Biotech, Appoints Jodi Brichan to Its Board of Directors
Regulatory Affairs Associate MCS Associates Mississauga, ON
PURA Targets $36 Billion Industrial Hemp Market With Farmersville Hemp Brand Strategy
The History of Seedsman
Chow420 Launches Blockchain Platform to Help Solve the Hemp CBD Market’s Trust and Safety Problem
Press Release: PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund
MyMD Pharmaceuticals Announces New Data Demonstrating 8,000 Times Higher Potency of Novel Synthetic Supera-CBD over Plant-Derived CBD
Two Thirds of Companies Say Compliance Is Key Barrier to Growth According To New Study from Fyllo and Harris Poll
A Majority of Companies in Tightly-Regulated Industries Say Compliance is Biggest Barrier
Virpax to Develop Intranasal Cannabidiol Product for the Management of Epilepsy in Adults and Children
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan
CBD Oil Global Market Insights Report 2021 – Analysis and Forecast to 2025 – ResearchAndMarkets.com
Press Release: Origin Therapeutics Announces First Five Portfolio Companies
MyMD Pharmaceuticals to Present its Novel Therapeutic Platforms for Extending Healthy Lifespan at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15
The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare
Australia: Regulatory Affairs Associate/Compliance Officer Little Green Pharma Perth CBD, Inner & Western Suburbs Healthcare & Medical Pharmaceuticals & Medical Devices
Anebulo Pharmaceuticals working on developing a fix for cannabis intoxication
Global Medical Cannabis Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com
Flora Lab Receives GMP Certification For Manufacturing Cosmetic Products Demonstrating Operational Excellence And Enabling Global Export Of Product Portfolio
Prohibition Publish 2nd Ed Of The Pharmaceutical Cannabis Report
Jamaica’s Manufacturing Sector to Play Strong Role in Economic Recovery
Lygos Announces Key Leadership Appointments
MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Use of Lead Candidate MYMD-1 for Treating Fibrosis and Asthma
How to Prevent Dementia: The Role of Cannabinoid Therapy
Marinus Pharmaceuticals Reports Topline Ganaxolone Phase 2 Open-Label Results in Tuberous Sclerosis Complex and Receives FDA Orphan Drug Designation
Tips for Establishing a Successful Cannabis Business
Mary AG Now Has Room to Grow Hemp in China Through CBDer Partnership
Fact check: How a new Colorado law affects access to medical cannabis
DLA Piper: Medical Cannabis: Proposed Changes and Legal Implications in the Czech Republic
DLA Piper:
Creo appoints commercial leader Graeme Kenny as Chief Revenue Officer
FDA Balks at CBD Dietary Supplement Application, Maintaining Regulatory Uncertainty
Does Cannabis Help Complex Tic Disorders Like Tourette Syndrome?
Does Cannabis Help Complex Tic Disorders Like Tourette Syndrome?
GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex
MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine
Canada: J&J’s Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules ‘Not An Innovative Drug’
Cannabis and Biotech Board Chair Arrested for Securities Fraud
Medxtractor Doubles Down on B2B Licensing & mHealth
THC-O Acetate Q&A with Dr. Ethan Russo: ‘Don’t Go There'
Global CBD-infused Products Market (2020 to 2028) – by Source, Type, and Distribution Channel – ResearchAndMarkets.com
Global Polyethylene (HDPE, LDPE & LLDPE) Market Report 2021-2025 with Potential Impact of COVID-19 – ResearchAndMarkets.com
Aurora Cannabis Announces Appointment of New Independent Director
Item 9 Labs Adds Multiple Senior Managers to Support Company Growth
NCIA Policy Report: The Medicine of Cannabis: An Overview for Medical Professionals and Policymakers
PsyIndex Weekly Update July 5, 2021 – July 9, 2021
Cannabis stocks celebrate Pershing ownership change
Medical Cannabis Co. GW Pharmaceuticals Agrees $7.2 Billion Takeover
Building a Cannabis Career in Uncertain Times
Jazz Pharmaceuticals Increases Guidance Based On GW Pharma Acquisition
GW Pharmaceuticals Wins the Queens Prize for Innovation
Press Release: Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms
Ontario company receives first-ever Health Canada approval to make cannabis pharmaceuticals
MyMD Pharmaceuticals Set to Join Russell Microcap® Index
Argentina Presents Cannabis, Hemp Industry Bill
The Big Beauty Promises of CBD Cream: Does it Really Work?
MyMD Pharmaceuticals Appoints David Rini, Professor at the Johns Hopkins School of Medicine, to Scientific Advisory Board
MyMD Pharmaceuticals Schedules Business Update Conference Call
Algernon Pharmaceuticals Announces 50% Enrollment of its Ifenprodil IPF and Chronic Cough Phase 2 Human Study
Jazz Closes On GW Pharma, Reports Results
Green Thumb Industries Has Captured Virginia
Her Maj Says Cannabis Meds OK ! GW Pharma Get Queen’s Award for Enterprise in Innovation
Johns Hopkins Medicine Researchers to Present Data on MyMD Pharmaceuticals’ Supera-CBD at the 3rd Annual Neuroimmunology Drug Development Summit
Cannabics Pharmaceuticals Launches a New Research Program to develop a Melanoma Treatment Drug Candidate for FDA Approval Track
MyMD Pharmaceuticals Announces Issuance of Allowance from United States Patent and Trademark Office for Synthetic Cannabinoid Compounds
London Is Open: Round Table Highlights
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
Former GW Pharmaceuticals CFO joins Beckley Psytech’s Board
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board
Why This Mexican Pharmaceutical Started Researching Cannabis
Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial
London Is Open: Round Table Highlights
Cannabis Companies on the London Stock Exchange
NY legal cannabis bill to gov’s desk (Newsletter: March 31, 2021)
Top Texas Lawmaker Reaffirms Support For Medical Marijuana And Decriminalization At Youth GOP Event
2021 Pipeline Insights into Scleroderma – Key Players Include Corbus Pharmaceuticals, Gesynta Pharma and Formation Biologics – ResearchAndMarkets.com
Algernon Pharmaceuticals Submits U.S. FDA Pre-IND Meeting Request for Psychedelic Drug DMT Clinical Research Program for Stroke
Press Release – Australia: Creso Pharma makes history as first ASX-listed psychedelics stock
Corbus Pharmaceuticals Beats Estimates For Fourth Quarter
Everything You Need To Know About CBDV
Zynerba Delivers Earnings, Long Road Ahead For Zygel
Ibere Pharmaceuticals Is The Quiet SPAC
London Is Open: Part 2
GOP Iowa Lawmaker Files Bill To Allow Psilocybin, MDMA And LSD Access For Seriously Ill Patients
M&A Uptick Expected to Continue in 2021: Q&A with Fox Rothschild Partner Melissa Sanders and Associate Jared Schwass
What the black market means for cannabis patents
GW Pharma to sell for $7.2 Billion, $GWPH jumps for $JAZZ
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharma Acquires GW Pharma for $7.2 Billion
February 4 2021: Jazz Pharmaceuticals buys GW Pharma for $7.2 billion
February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion
Jazz Pharmaceuticals Pick Up GW Pharma For A Cool $7.2 billion
Jazz Pharma Acquires GW Pharma for $7.2 Billion
Medical cannabinoid firm GW Pharma to be acquired by Jazz Pharmaceuticals for $7.2 billion
Survey says cannabis is America’s favourite way to kick opiates
CBD could be the bacterial-killing answer to gonorrhoea
GW Pharma expects fiscal 2020 sales to reach $526 million
Cannabis companies can now list on the London Stock Exchange
You must be logged in to post a comment.